OTCMKTS:ABAHF - Abacus Health Products Stock Price, News, & Analysis

-0.09 (-1.32 %)
(As of 07/21/2019 11:30 AM ET)
Today's Range
Now: $6.75
50-Day Range
MA: $7.41
52-Week Range
Now: $6.75
Volume1,862 shs
Average Volume3,064 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Abacus Health Products, Inc. manufactures and sells over-the-counter (OTC) topical formulations infused with cannabidiol (CBD) extracted from hemps. The company offers CBD CLINIC line of products for relief from acute musculoskeletal and joint pain, which includes analgesic ointments, creams, and pain sticks, as well as analgesic massage oils. It also provides CBDMEDIC line of products, such as sport ointments and pain sticks, back and neck ointments, arthritis hand creams and ointments, and massage therapy oils, as well as ointments and pain sprays for muscles and joints. The company offers its CBD CLINIC products to registered health practitioners, including chiropractors, acupuncturists, massage and physical therapists, naturopaths, and osteopaths; and CBDMEDIC products directly to consumers through retail pharmacy chains and fitness locations, as well as online through the e-commerce platform. In addition, it is involved in developing a pipeline of other OTC CBD products addressing additional medical indications and the health and wellness sectors. The company is headquartered in Toronto, Canada. Abacus Health Products, Inc. is a subsidiary of Aidance Skincare & Topical Solutions, LLC.

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable

Receive ABAHF News and Ratings via Email

Sign-up to receive the latest news and ratings for ABAHF and its competitors with MarketBeat's FREE daily newsletter.

Abacus Health Products (OTCMKTS:ABAHF) Frequently Asked Questions

What is Abacus Health Products' stock symbol?

Abacus Health Products trades on the OTCMKTS under the ticker symbol "ABAHF."

Has Abacus Health Products been receiving favorable news coverage?

Media headlines about ABAHF stock have trended extremely negative this week, according to InfoTrie Sentiment. The research firm identifies negative and positive press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Abacus Health Products earned a media sentiment score of -4.7 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the immediate future. View News Stories for Abacus Health Products.

Who are some of Abacus Health Products' key competitors?

What other stocks do shareholders of Abacus Health Products own?

How do I buy shares of Abacus Health Products?

Shares of ABAHF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Abacus Health Products' stock price today?

One share of ABAHF stock can currently be purchased for approximately $6.75.

What is Abacus Health Products' official website?

The official website for Abacus Health Products is http://abacushp.com/.

MarketBeat Community Rating for Abacus Health Products (OTCMKTS ABAHF)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  5 (Vote Outperform)
Underperform Votes:  4 (Vote Underperform)
Total Votes:  9
MarketBeat's community ratings are surveys of what our community members think about Abacus Health Products and other stocks. Vote "Outperform" if you believe ABAHF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ABAHF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/21/2019 by MarketBeat.com Staff

Featured Article: What is a Swap?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel